Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
The Real Rate Index45.30.00Palanor: Inflation Pulse50.7+0.09Palanor: Geopolitical Stress60.0-2.16Palanor: Liquidity57.9-0.79Palanor: Capital Tightness47.5+0.91Palanor: Industrial Pulse70.10.00Palanor: AI Margin Compression53.4+0.29Palanor: Consumer Confidence48.6+0.50Palanor: US Dollar Strength46.50.00Palanor: Labor Heat63.2-0.01Palanor: Recession Vocabulary28.1+0.54Palanor: Uncertainty Index53.4+1.24Palanor: US Jobs Health40.30.00Palanor: Energy Transition37.0-0.52Palanor: Reshoring Sentiment22.8+0.54Palanor: AI Substitution28.4-0.24The Social Fabric Index45.70.00Palanor: Geopolitical Anxiety19.4-0.45Palanor: Quit Pressure37.6+0.42The Mania Index88.00.00The Palanor Index57.1-0.51Cost Disease Spread33.20.00Palanor: US vs China49.5-0.17Rise of Socialism Index40.8-0.26The Bubble Memory79.90.00Palanor: Steward Confidence50.8+0.13The Long Watch90.30.00The Reshoring Index55.2+0.00The Capital Return Index81.0-0.75The Discourse Index72.4+1.83The Hesitation Index30.8-6.58Palanor AI Inference Cost Index71.2-0.03The AI Capex Race Index78.4+1.36The Boardroom Index82.5-0.00The Layoff Cycle Index32.8-2.51Capital Deployment Posture Index62.3+1.26The Consumer Health Index41.7-2.96Labor Hours Composite44.40.00The Dollar Erosion Index66.6+0.14Palanor: Risk Appetite36.2+0.83
PalanorPalanor

Company Dossier · Health Care

Illumina, Inc.

ILMNNasdaqLife Sciences Tools & ServicesWILMINGTON, US-DE, USLarge capWebsite ↗
  • S&P 500
  • Russell 1000

What Illumina, Inc. is doing, read from its filings, its own words and the news, with every figure dated and sourced. Not investment advice: no ratings, no price targets.

Open the full company record in Palanor: guidance, KPIs, ownership, calls, prices →

The latest read

Computed from the data on Oct 22, 2026. Every figure links back to its source in the sections below.

  • Revenue over the four quarters to June 28, 2026: $4.49 billion, up 4.9% from a year earlier.SEC EDGAR filings (XBRL)
  • Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 28, 2026: $0.93 billion, down 9.7% from a year earlier.SEC EDGAR filings (XBRL)
  • Capital expenditure over the four quarters to June 28, 2026: $0.16 billion, up 33% from a year earlier.SEC EDGAR filings (XBRL)
  • Share buybacks in the fiscal year to December 28, 2025: $0.74 billion.SEC EDGAR filings (10-K)
  • Long-term debt issued in the fiscal year to December 28, 2025: $0.50 billion.SEC EDGAR filings (10-K)
  • Latest earnings call or results release (July 30, 2026): sentiment 0.80 on a −1 to +1 scale (confident, opportunity-framed), confidence 0.90 of 1.Palanor Discourse
  • Latest annual report (filed February 12, 2026): 1 risk factor added, 2 removed.Risk Factor Changes (10-K Item 1A)
  • Insiders were net sellers in Q3 2026: $436 million on the open market.SEC Form 4
  • 938 institutional managers reported a position at June 30, 2026 (+89 on the quarter before).SEC Form 13F
  • H-1B filings certified in Q2 2026: 44 (47 a year earlier).U.S. Department of Labor (OFLC)

Risk events (12 months): 1 — latest OSHA inspection, Nov 17, 2025 →

Company Posture

How Company Posture is measured →

What Illumina, Inc. is doing, on three axes, from its filings and its own words, as of 2026-10-22. A description, not a rating: Company Posture never says whether to buy.

Expanding · Confident

Expanding ↔ Retrenching

Expanding

RetrenchingExpanding

Confident ↔ Hedging

Confident

HedgingConfident

Pressure

Components only: Not yet shown as a score: in the back-test it did not add to a naive reader's forecast of impairment, debt acceleration or bankruptcy filings (8-K 2.06, 2.04, 1.03) (not enough events (17 in half 1; needs 20)).

Credit

How these are built →

Illumina, Inc.'s borrowing from its SEC filings: the bonds it priced and the debt on its latest balance sheet. A description, not a rating.

Debt on the balance sheet

$2.0B

  • Due within a year $0.5B
  • Longer term $1.5B
  • Default point $1.2B (short + ½ long)

Finance leases included · Jun 28, 2026 filing

Bonds priced, last 12 months

$0.8B

U.S. dollar tranches with a term sheet on EDGAR. Deals sold under Rule 144A file none and are not counted.

PricedAmountCouponMaturesSpreadYield
Aug 10, 2026$300M4.950%2029 (3y)+65bp4.958%
Nov 10, 2025$500M4.750%2030 (5y)+105bp4.758%
Sep 4, 2024$500M4.650%2026 (2y)+90bp4.687%

From the pricing term sheets Illumina, Inc. filed with the SEC. Spread is to the benchmark Treasury (or Bund, Gilt) at pricing.

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

Cash flow

Business

Illumina, Inc.: free cash flow, trailing twelve months

Operating cash flow minus capital expenditure, $ billions, from SEC filings

$0.9BData to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Illumina, Inc.: operating cash flow and capital expenditure

Trailing twelve months, $ billions, from SEC filings

Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Illumina, Inc.: revenue, trailing twelve months

$ billions, from SEC filings

$4.5BData to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

Capital returned and raised

Business

Illumina, Inc.: share buybacks by fiscal year

Cash paid to repurchase common stock, $ billions, from the 10-K

$0.74BData to Dec 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Illumina, Inc.: debt issued and repaid by fiscal year

Long-term debt, $ billions, from the 10-K

Data to Dec 2025
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Illumina, Inc.: debt due within a year and cash

At each balance-sheet date, $ billions, from SEC filings

Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Illumina, Inc.: interest coverage

Operating income ÷ interest expense, trailing twelve months, from SEC filings

9.0Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

What the company says

Business

Illumina, Inc.: earnings call sentiment

Palanor Discourse score per call, −1 to +1

0.80Data to Jul 2026
ImageDataPalanor calculation
Business

Illumina, Inc.: earnings call confidence

Palanor Discourse score per call, 0 to 1

0.90Data to Jul 2026
ImageDataPalanor calculation
Business

Illumina, Inc.: risk factors added per annual report

New Item 1A risk factors in each 10-K

1.0Data to Feb 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

Hiring and ownership

Business

Illumina, Inc.: H-1B filings certified

Labor Condition Applications by quarter received

44.0Data to Jun 2026
ImageDataU.S. Department of Labor, Office of Foreign Labor Certification disclosure data, dol.gov
Business

Illumina, Inc.: insider net buying

Open-market purchases minus sales by officers and directors, $ millions, by quarter

−$436.5MData 23 days ago
ImageDataU.S. Securities and Exchange Commission, EDGAR
Business

Illumina, Inc.: institutional holders

Managers reporting a position on Form 13F, by quarter

938.0Data to Jun 2026
ImageDataU.S. Securities and Exchange Commission, EDGAR

In the news

Headlines that name Illumina, Inc., with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.

30 days
2 headlines
0% positive · 0% negative
90 days
2 headlines
0% positive · 0% negative

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

  1. Oct 21, 2026Lobbying
    Lobbying report (ILLUMINA, INC.)third_quarter 2026 · $0.2 million
  2. Oct 20, 2026Lobbying
    Lobbying report (AVENUE SOLUTIONS)third_quarter 2026 · $0.1 million
  3. Oct 20, 2026Lobbying
    Lobbying report (MILLER STRATEGIES, LLC)third_quarter 2026 · $0.1 million
  4. Oct 20, 2026Lobbying
    Lobbying report (AKIN GUMP STRAUSS HAUER & FELD)third_quarter 2026 · $0.0 million
  5. Oct 20, 2026Lobbying
    Lobbying report (THORN RUN PARTNERS)third_quarter 2026 · $0.0 million
  6. Oct 19, 2026Lobbying
    Lobbying report (TODD STRATEGY GROUP)third_quarter 2026 · $0.1 million
  7. Oct 19, 2026Lobbying
    Lobbying report (AKIN GUMP STRAUSS HAUER & FELD)third_quarter 2026
  8. Oct 18, 2026Lobbying
    Lobbying report (JEFFREY J. KIMBELL AND ASSOCIATES)third_quarter 2026 · $0.0 million
  9. Oct 13, 20268-K
    Material agreement signedItem 1.01
  10. Oct 13, 2026Patent
    Patent granted: COMPOSITIONS AND METHODS FOR CAPTURING AND AMPLIFYING TARGET POLYNUCLEOTIDES USING MODIFIED CAPTURE PRIMERSUS 12760356
  11. Oct 13, 2026Patent
    Patent granted: SPECIALIST SIGNAL PROFILERS FOR BASE CALLINGUS 12763166
  12. Oct 13, 2026Patent
    Patent granted: VARIANT PATHOGENICITY SCORING AND CLASSIFICATION AND USES THEREOFUS 12762151
  13. Oct 13, 2026Patent
    Patent granted: SYSTEM AND METHOD FOR SEQUESTERED WASH BUFFER REUSEUS 12758966
  14. Oct 13, 2026Patent
    Patent granted: QUALITY SCORE COMPRESSIONUS 12763169
  15. Aug 13, 20268-K
    Material agreement signedItem 1.01
  16. Aug 13, 20268-K
    Material agreement terminatedItem 1.02
  17. Jun 23, 20268-K
    Director or officer changeItem 5.02
  18. Jun 4, 2026Trademark
    Trademark application: STRATAMAP
  19. Jun 4, 2026Trademark
    Trademark application: DRAGEN STRATAMAP
  20. May 26, 20268-K
    Shareholder vote resultsItem 5.07
  21. May 13, 2026Trademark
    Trademark application: SOMASEQ
  22. Apr 2, 20268-K
    Director or officer changeItem 5.02
  23. Feb 12, 202610-K
    Annual report (10-K)1 risk factors added, 2 removed
  24. Jan 30, 20268-K
    Acquisition or sale completedItem 2.01
  25. Jan 8, 20268-K
    Director or officer changeItem 5.02
  26. Dec 19, 2025Trademark
    Trademark application: CHATDNA
  27. Nov 17, 2025Risk event
    OSHA complaint inspection: ILLUMINA, INC.OSHA
  28. Oct 9, 2025Trademark
    Trademark application: TRUPATH
  29. Jun 23, 20258-K
    Material agreement signedItem 1.01
  30. May 23, 20258-K
    Director or officer changeItem 5.02
  31. May 23, 20258-K
    Shareholder vote resultsItem 5.07
  32. Mar 25, 20258-K
    Director or officer changeItem 5.02
  33. Mar 24, 20258-K
    Director or officer changeItem 5.02
  34. Feb 12, 202510-K
    Annual report (10-K)
  35. Jan 14, 20258-K
    Exit or restructuring costsItem 2.05

Peers

Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

CompanyRevenueFree cash flowThrough
Waters Corporation WAT$4.6B—Jul 4, 2026
Mettler Toledo MTD$4.1B$0.9BJun 30, 2026
Charles River Laboratories CRL$4.0B$0.4BJun 27, 2026
Agilent Technologies A$7.4B$1.3BJul 31, 2026
Bio-Rad Laboratories BIO$2.6B$0.3BJun 30, 2026
Bio-Techne TECH$1.2B$0.3BJun 30, 2026
IQVIA IQV$16.6B$2.1BMar 31, 2026
Idexx Laboratories IDXX$4.5B$1.3BJun 30, 2026

Identity

SEC CIK
1110803
LEI
SQ95QG8SR5Q56LSNF682
Wikidata
Q2068984

Built from SEC EDGAR filings (public domain), the Guidance and KPI Ledgers, Palanor Discourse, U.S. Department of Labor filings, USPTO, USAspending and Senate lobbying records, and rights-checked news headlines. Updated nightly; this page was built Oct 22, 2026. How the Dossier is built

S&P 500, S&P 100, S&P MidCap 400 and Dow Jones Industrial Average are trademarks of S&P Dow Jones Indices LLC or its affiliates; Nasdaq-100 is a trademark of Nasdaq, Inc.; Russell 1000 is a trademark of FTSE Russell. Membership is shown for identification only. Palanor is not affiliated with or endorsed by the index owners.

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.